1. Introduction {#sec1}
===============

Treatment of disease by multiple dosing strategies and using conventional drug formulation poses many drawbacks \[[@B1]\]. Among them are fluctuation of drug plasma concentration, the various side effects due to toxic plasma level of drug, or ineffectiveness treatment because of the lower concentration of drug than its therapeutic index \[[@B2], [@B3]\]. Another important limitation of multiple dosing regimens is poor patient compliance especially for diseases for which patient must take drugs for a long time such as epilepsy \[[@B4], [@B5]\] or for some specific drugs such as naltrexone hydrochloride which is used for maintenance abstinence in detoxified addicted persons after withdrawal phase of opioids and alcohol \[[@B6], [@B7]\].

Nowadays scientists are interested in novel drug delivery systems which are used to direct drugs to the specific site of action and to achieve a controlled release of drug with a desirable release kinetics \[[@B1], [@B8]\]. Among the most studied of these systems are hydrogels which are insoluble matrices of hydrophilic block copolymers which swell in presence of fluids \[[@B9], [@B10]\]. Smart hydrogels are the polymeric networks which release drugs in response to the environmental parameters such as temperature \[[@B11]--[@B13]\], pH \[[@B14], [@B15]\], light \[[@B16], [@B17]\], magnetisms \[[@B18], [@B19]\]. Thermoresponsive hydrogels are extensively investigated smart hydrogels because of their simple application, low adverse effect on tissues compared with some other stimuli, and the difference between room and body temperature \[[@B12], [@B20]\].

Amphiphilic triblock copolymers, PCL-PEG-PCL, composed of polyethylene glycol (PEG) and poly (*ε*-caprolactone) (PCL), form a thermoresponsive, in situ forming, and biodegradable hydrogel \[[@B21], [@B22]\] which have been studied as drug delivery systems \[[@B23]--[@B25]\].

MW irradiation for the high-speed, reproducible, and scalable preparation of polymeric materials has been utilized to reduce reaction times from days and hours to minutes and seconds and facilitate scale-up procedure and technology transfer from bench to industry \[[@B26], [@B27]\].

In this study, PCL-PEG-PCL with various weight ratios of each block of copolymer (PCL: PEG: PCL), 1000 : 1000 : 1000 and 500 : 1000 : 500, was synthesized by three different methods: using stainless steel reactor, two-necked round-bottomed flask, and under microwave irradiation. Structure, molecular weight (Mw), and sol-gel transition of copolymers were investigated. Also in vitro drug release behavior was evaluated in this study using naltrexone hydrochloride and vitamin B~12~.

2. Materials {#sec2}
============

Poly (ethylene glycol) (PEG, Mn = 1000, Merck, Germany), *ε*-caprolactone (Sigma Aldrich, USA), stannous octoate (Sn(Oct)~2~, Sigma Aldrich, USA), naltrexone hydrochloride was kindly donated by Razak Co., Iran, and vitamin B~12~ were kindly donated by Iran Hormone Co., Iran.

3. Methods {#sec3}
==========

3.1. Synthesis and Purification of PCL-PEG-PCL Copolymers {#sec3.1}
---------------------------------------------------------

Synthesis of PCL-PEG-PCL copolymers was carried out with two different block lengths of (PCL: PEG: PCL): 1000 : 1000 : 1000 (copolymer 1) and 500 : 1000 : 500 (copolymer 2) by a ring-opening polymerization technique. The synthesis in stainless steel reactor and two-necked round-bottomed flask was performed as described before by Gong et al. \[[@B21], [@B28]\]. The copolymer was also synthesized using microwave irradiation. Briefly to synthesize 1000 : 1000 : 1000, 10 g dried PEG1000, 20 g *ε*-caprolactone, and 2 g Sn(Oct)~2~ were added to a glassy flask fitted with condenser and was placed in a microwave. The mixture was irradiated and stirred at 800 watt while temperature was kept at 130°C. The irradiation time was different in each synthesis (15, 20, 25 min) to choose an optimum time for rapid preparation of the copolymer.

In order to purify the product, at first, obtained copolymers were dissolved in 20 mL dichloromethane. By gradually adding 800 mL of petroleum ether, the viscous copolymer precipitants appeared. At the final step, the precipitants were filtered. The purification process was done 3 times and the final product was dried by freeze drying method \[[@B29]\].

The yield of reaction by each method was calculated by dividing the weight of the purified PCL-PEG-PCL to the weight of initial materials used in the polymer preparation.

3.2. Characterization of the PCL-PEG-PCL Copolymer {#sec3.2}
--------------------------------------------------

The copolymer structure and number-average molecular weights (Mn) were determined using Nuclear Magnetic Resonance Analysis (^1^H-NMR, AC 80 Brucker, Germany) at 80 MHZ and 25°C in CDCL~3~ \[[@B21]\].

Gel permeation chromatography (GPC, Agilent GPC-Addon apparatus and RID-A refractive index signal detector coupled to Plgel columns) was utilized to determine the weight-average molecular weight (Mw), Mn, and polydispersity of the block copolymers using tetrahydrofuran as the solvent and eluent with a rate of 1 mL/min and polystyrene as the calibration standard \[[@B29]\].

3.3. Evaluation of the Phase Transition of the PCL-PEG-PCL Copolymer {#sec3.3}
--------------------------------------------------------------------

To determine the sol to gel and gel to precipitant transition temperatures, 3 mL of the copolymers solution in distilled water (15, 20, 25, and 30% (w/v)) was poured in to 5 mL vials kept in a refrigerated bath circulator (P-22 WISD, South Korea). The temperature increased with a rate of 1°C/3 min from 10 ± 0.1 to 60 ± 0.1°C. After each 3 min, the vials were inverted to evaluate the viscosity of the content. The temperature which the content did not flow by inverting vials was assumed as the sol-gel transition temperature. An increase in temperature was continued and the precipitation temperature was also recorded \[[@B21]\]. This study was done before and after drug loading to determine the effect of drug on the phase transition temperatures. The reversibility of the gel and the precipitant forming was also investigated by decreasing the temperature. To determine the time of the formation of the gels, all samples were transferred to a 37°C water bath (N-Biotek-304, South Korea) and the time of sol-gel transition was recorded. All experiments were performed 3 times.

3.4. In Vitro Drug Release Study {#sec3.4}
--------------------------------

According to the result of the polymer characterizations and the phase transition evaluations, two appropriate concentrations of copolymer 1 (1000-1000-1000), which was synthesized by a microwave irradiation in 15 min, were chosen as a drug delivery system for the in vitro drug release experiment. For the purpose of preparing drug loaded hydrogels, adequate amount of the copolymer was dissolved in a naltrexone hydrochloride or vitamin B~12~ solution in distilled water. The blank was the copolymer solution without drug. [Table 1](#tab1){ref-type="table"} presents the different samples that were used in this experiment. The entire samples were prepared in triplicate. 2 mL of each formulation was placed in tubes and was transferred to the reciprocal water bath at 37°. After the formation of the hydrogels, 4 mL of the phosphate buffer solution (PBS, pH = 7.4) was added to each sample tube as a release media and samples were shaken at a rate of 60 times/min. In each sampling time, 0.5 mL of the medium was withdrawn and replaced by 0.5 mL fresh buffer. Drug analysis in samples was performed using high performance liquid chromatography (HPLC, Acme 9000 Young Lin, South Korea, C18 (4.6 × 250 mm, 52 *μ*m) column). Mobile phase for naltrexone hydrochloride was composed of 14% acetonitrile, 85.5% deionized water, and 0.5% acetic acid (v/v) and for B~12~ was a mixture of 30% methanol and 70% deionized water. The flow rate in both analyses was 1 mL/min and the UV detection wave length was set at 281 and 305 nm for naltrexone hydrochloride and B~12~, respectively.

3.5. Statistical Analysis {#sec3.5}
-------------------------

The results were presented as means ± SDs (*n* = 4). Paired *t*-test and one-way ANOVA were used to analyze them. A significance level was *P* \< 0.05 in all cases.

4. Results and Discussion {#sec4}
=========================

4.1. Copolymer Characterizations {#sec4.1}
--------------------------------

In order to compare different copolymer synthesis methods, The copolymerization was done by three different procedures that two of them, using two-necked flask and the stainless steel reactor, were conventional methods and take longer time compared to the other method which was a high-speed microwave-assisted way of the copolymer synthesis. Since the microwave heating process provided a reaction condition with a higher temperature and pressure, the reaction took relatively short times and also the side reaction was limited and consequently greater yields were usually obtained \[[@B27]\]. According to the yield of each method ([Table 2](#tab2){ref-type="table"}), the microwave-assisted synthesis was the best method in which the reaction just took a few minutes. By increasing the time of the reaction from 15 min to 25 min, no significant difference was found in the yield of the reaction or the quality of the products. Thus we considered 15 min as an adequate time for the microwave-assisted synthesis of the PCL-PEG-PCL copolymers. Yields of the copolymers synthesized by the stainless steel reactor method were a little higher than the two-necked flask method.

The ^1^H-NMR spectrum of the PCL-PEG-PCL (1000-1000-1000) synthesized by the stainless steel reactor is shown in [Figure 1](#fig1){ref-type="fig"}. The signals appeared in 3.6 (A), 4.1 (h), 2.2 (d), and 1.5 (e, f, g) ppm are related to the protons of PEG (A) and the CH~2~ groups of caprolactone (h, d, e, f, g) \[[@B29]\]. The Mn of the copolymer was calculated by the integration of the signals pertaining to each monomer. Mn of the copolymer (1000-1000-1000) synthesized by the reactor and the microwave (15 min) were 2590 and 3412, respectively. As the Mn of the copolymers indicated, the one which was prepared by the reactor, in contrast to the one which prepared by the microwave-assisted method, has Mn lower than the theoretical amount (3000). [Figure 2](#fig2){ref-type="fig"} exhibits the GPC chromatogram of copolymer 1 prepared by the microwave irradiation. Symmetric peak of the chromatogram confirmed the low polydispersity of the copolymer. Mw and Mn obtained from ^1^H-NMR and GPC, the polydispersity of the copolymer which was estimated by Mw/Mn obtained from GPC, and the caprolactone (CL) to PEG ratio obtained from ^1^H-NMR are presented in [Table 3](#tab3){ref-type="table"}. The data in [Table 3](#tab3){ref-type="table"} belongs to copolymer 1 synthesized by the microwave-assisted method.

4.2. The Phase Transition Behavior {#sec4.2}
----------------------------------

The PCL-PEG-PCL tri-block copolymers are in situ gel-forming thermo-responsive copolymers composed of the hydrophobic PCL and the hydrophilic PEG blocks. When hydrophobic blocks of PCL are surrounded by water molecules, they aggregate to reduce their exposed surface area in an aqueous environment and form micelles. But this phenomenon is temperature dependent. In temperatures below (lower critical solution temperature) LCST, since there is hydrogen bonding between hydrophilic PEG blocks and water molecules, the system is in sol condition and contains micelles. By increasing the temperature above LCST, weakening of the hydrogen bonds and the formation of the hydrophobic bridge between micelles through PCL segments cause the system to become gel. If increasing the temperature continues, the copolymers are phased out \[[@B29]\].

The sol-gel transition temperatures of the copolymers with various concentrations are presented in [Table 4](#tab4){ref-type="table"}. Copolymer 1 (1000-1000-1000) could form gel in all concentrations, but copolymer 2 (500-1000-500) prepared by both conventional synthesis method could not form gel at the concentration of 15% and not even at the concentration of 20% for the two-necked flask method (w/v) due to its shorter hydrophobic segments (CL) compared to copolymer 1 and an incomplete copolymer synthesis by these methods. Although the copolymer 1 (1000-1000-1000) formed gel in all concentrations, the sol-gel transition occurred in lower temperatures when it was synthesized using the microwave irradiation (*P* \< 0.05). In all methods, as the copolymer concentrations increased, the phase transition temperatures shifted to the lower temperatures due to an increase in hydrophobic interactions. There was no significant difference between the gel forming temperatures of the copolymers synthesized by the microwave method in different reaction times (*P* \> 0.05). The phase transition temperatures in all concentrations of copolymer 1 synthesized by the microwave irradiation were below the room temperature. This causes copolymer 1 synthesized by the microwave to become a good candidate for an injectable carrier which converts to the gel in the body and releases the drug loaded inside in a sustained and controlled manner. The phase transition temperatures of all copolymers synthesized by the conventional methods were above the body temperature and therefore could not gel in the body and were not suitable as a drug carrier.

Another limitation of the conventional synthesized copolymers was the delay in gel formation that may cause a dose dumping effect in the body. For the microwave-assisted synthesized copolymers, the sol-gel transition occurred in about 20 seconds, whereas this amount was 20 min for some of the copolymers synthesized by the conventional methods.

The effect of the copolymer concentration on the phase transition temperature was shown in [Figure 3](#fig3){ref-type="fig"}. As it is indicated, by increasing copolymer 1 concentration (microwave synthesized), the sol-gel transition temperatures decreased and the precipitation temperatures increased due to a larger number of hydrophobic interactions.

We also investigated the effect of the drug content on the sol-gel transition temperature. As it was indicated in [Table 5](#tab5){ref-type="table"}, loading vitamin B~12~, a large molecule having 9 positions on it that can form hydrogen bonds with water molecules, lowered the activity of water and favored hydrophobic interactions between the PCL blocks of the copolymers. However, loading a fairly small molecule such as naltrexone hydrochloride in copolymers does not have a significant effect on the phase transition temperatures.

4.3. In Vitro Drug Release Study {#sec4.3}
--------------------------------

In vitro drug release through the PCL-PEG-PCL (1000-1000-1000) synthesized by the microwave-assisted method was investigated at different concentrations of the copolymer and the drugs. The drug models used in this experiment were naltrexone hydrochloride and vitamin B~12~. The results are presented in Figures [4](#fig4){ref-type="fig"}--[6](#fig6){ref-type="fig"}. The rate of drug release through the hydrogels with the same concentration of the copolymer but a different concentration of the drug was not significant; just a negligible increase in the rate of drug release after an increase in naltrexone hydrochloride concentration was observed. This could be due to the fact that naltrexone hydrochloride, which is a small molecule in contrast to B~12~, was released by diffusion rather than the hydrogel degradation. According to the Fick\'s law of diffusion, increasing drug concentration causes the rate of diffusion and the consequent drug release increases \[[@B30]\]. As it is shown in Figures [4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}, the release of naltrexone hydrochloride and vitamin B~12~ through the hydrogels with higher copolymer concentration was slower. This could be attributed to the fact that higher copolymer concentration made the hydrogels low porous with a big tortuosity and viscosity. Here, the effect of the molecular weight on the drug release through the hydrogels was also investigated by comparing the naltrexone hydrochloride and vitamin B~12~ loaded systems. As indicated in [Figure 6](#fig6){ref-type="fig"}, vitamin B~12~ with a higher molecular weight (MW = 1355) compared to naltrexone hydrochloride (MW = 373), was released more slowly than naltrexone hydrochloride. The release kinetics of both drugs was determined by fitting data according to zero order (release by hydrogel erosion) and Higuchi kinetic models \[[@B31], [@B32]\]. Since *R* ^2^ of both models were approximately similar in all formulations, it was assumed that both mechanisms of diffusion and the hydrogel erosion played an important role in the drug release through the hydrogels ([Table 6](#tab6){ref-type="table"}).

5. Conclusion {#sec5}
=============

Synthesis of PCL-PEG-PCL using microwave irradiation is the fast, simple, and cost effective method which causes higher yield of reaction. PCL 1000-PEG 1000-PCL 1000 tri-block copolymer solution which forms gel in body temperature even with low concentration of polymer appears to be a suitable in situ forming system as the pharmaceutical and clinical purpose. Different parameters such as polymer concentration and drug structure have influence on profile of drug release from systems. The release kinetics is mix of diffusion and hydrogel degradation.

This project was supported by a grant from Vice Chancellor of Research, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran. The results described in this paper were part of a Pharm D student thesis proposal related to Mr A. Golmohammadian. Kind donation of Vitamin B~12~ by Iran Hormone Co. and naltrexone hydrochloride by Razak Co. is also appreciated.

![^1^H-NMR spectrum of the tri-block copolymer of PCL-PEG-PCL (1000-1000-1000).](ISRN.PHARMACEUTICS2012-976879.001){#fig1}

![GPC chromatogram of the tri-block copolymer of PCL-PEG-PCL (1000-1000-1000).](ISRN.PHARMACEUTICS2012-976879.002){#fig2}

![Effect of the PCL-PEG-PCL (1000-1000-1000) concentrations on the phase transition temperature.](ISRN.PHARMACEUTICS2012-976879.003){#fig3}

![B~12~ release from copolymer (1000-1000-1000) with different concentration of drug and polymers.](ISRN.PHARMACEUTICS2012-976879.004){#fig4}

![Naltrexone hydrochloride (Nal) release from copolymer (1000-1000-1000) with different concentration of drug and polymers.](ISRN.PHARMACEUTICS2012-976879.005){#fig5}
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###### 

Samples used in the in vitro drug release study.

  No.   Concentration of the B~12~ solution(w/v %)   Concentration of the copolymer solution (w/v %)   No.   Concentration of the naltrexone hydrochloride solution (w/v %)   Concentration of the copolymer solution (w/v %)
  ----- -------------------------------------------- ------------------------------------------------- ----- ---------------------------------------------------------------- -------------------------------------------------
  1     0                                            20                                                11    0                                                                20
  2     0                                            25                                                12    0                                                                25
  3     0.1                                          20                                                13    0.1                                                              20
  4     0.1                                          25                                                14    0.1                                                              25
  5     0.5                                          20                                                15    0.5                                                              20
  6     0.5                                          25                                                16    0.5                                                              25

###### 

Comparison of different synthesis methods based on the time and the yield of the reaction.

  Kind of the copolymer   Synthesis method          Time of the reaction   Yield of the reactions (%)
  ----------------------- ------------------------- ---------------------- ----------------------------
  Copolymer 1             Two-necked flask          6 hours                56
  Copolymer 2             Two-necked flask          6 hours                68
  Copolymer 1             Stainless steel reactor   6 hours                73
  Copolymer 2             Stainless steel reactor   6 hours                79
  Copolymer 1             Microwave irradiation     25 min                 93
  Copolymer 1             Microwave irradiation     15 min                 95
  Copolymer 1             Microwave irradiation     20 min                 96

###### 

The triblock copolymer 1 (1000-1000-1000) composition determined by GPC and ^1^H NMR.

  GPC    NMR                   
  ------ ------ ------ ------- ----------------
  1.49   5895   3936   2.412   1206-1000-1206

###### 

Sol-gel transition temperatures of different PCL-PEG-PCL copolymers (°C).

  --------------------------------------------------------------------------------------------------------------------------------------
  Conc.\    copolymer 1\       copolymer 1\       copolymer 1\       copolymer 1\   copolymer 2\   copolymer 1\       copolymer 2\
  (w/v %)   microwave 25 min   microwave 20 min   microwave 15 min   reactor        reactor        two-necked flask   two-necked flask
  --------- ------------------ ------------------ ------------------ -------------- -------------- ------------------ ------------------
  15%       26.25 ± 0.5        27 ± 0             26.5 ± 0.58        53 ± 1.83      No Gel         56.25 ± 1.2        No Gel

  20%       23 ± 0.82          23.25 ± 0.5        23.25 ± 0.5        49.75 ± 1.5    55 ± 2.16      50.75 ± 0.9        No Gel

  25%       18.5 ± 0.58        18.75 ± 0.5        18.75 ± 0.9        45.5 ± 1.73    53 ± 1.41      45.25 ± 0.5        54.75 ± 0.9

  30%       15.75 ± 0.9        15.5 ± 0.58        15.25 ± 1.2        42 ± 1.41      48.5 ± 0.5     43.75 ± 0.7        51.25 ± 0.9
  --------------------------------------------------------------------------------------------------------------------------------------

###### 

The effect of drug loading on the sol-gel transition temperature.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Copolymer concentration\   sol-gel transition temperature without drug   sol-gel transition temperature\   sol-gel transition temperature\   sol-gel transition temperature naltrexone\   sol-gel transition temperature naltrexone\
  (w/v %)                                                                  B~12~ (0.1%)                      B~12~ (0.5%)                      HCl (0.1%)                                   HCl (0.5%)
  -------------------------- --------------------------------------------- --------------------------------- --------------------------------- -------------------------------------------- --------------------------------------------
  20%                        23.25 ± 0.5                                   21.67 ± 0.58                      21.33 ± 0.58                      22.67 ± 0.58                                 21.67 ± 0.58

                                                                                                                                                                                            

  25%                        18.75 ± 0.96                                  18 ± 1                            16.33 ± 0.58                      18.33 ± 0.58                                 18 ± 0
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Kinetic profile of drug release.

  Drug                       Drug concentration (w/v %)   PCL-PEG-PCL concentration (w/v %)   Zero order   Higuchi
  -------------------------- ---------------------------- ----------------------------------- ------------ ---------
  Naltrexone hydrochloride   0.1                          20                                  0.938        0.993
  25                         0.966                        0.982                                            
  0.5                        20                           0.951                               0.985        
  25                         0.966                        0.983                                            
                                                                                                           
  Vitamin B~12~              0.1                          20                                  0.928        0.993
  25                         0.942                        0.993                                            
  0.5                        20                           0.934                               0.990        
  25                         0.946                        0.994                                            
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